Get one-on-one support from experienced founders, investors, and subject-matter experts.
Schedule a one-on-one session with our experienced mentors during their regular office hours. Resident startups and the Northwestern community welcome. Complete the interest form below to apply for one-on-one session with our experienced mentors.
Advises on: Medical technology companies, product and business model strategy, identifying and developing transformational innovations
Chief R&D Officer / Chief Investment Officer
Kairos Ventures
Advises on: Pitch, business plan, strategic alternatives
Founder & CEO
SPRIG
Advises on: Market development, launch, commercialization
Founding Scientist, EVP Drug Discovery & Early Development
Flare Therapeutics
Advises on: Science, company formation, drug development
Associate Director, Alliances and Program Management
Caliber at Scripps Research
Advises on: Therapeutic discovery, therapeutic development plans, industry landscape
Invention Manager, INVO
Northwestern University
Advises on: Critical path milestones, failure modes, talent acquisition
Managing Director
Gen 1 Capital
Advises on: Opportunity, launch, operations, funding, governance, strategy
Venture Associate
Evergreen Climate Innovations
Advises on: Development cycles, pitch, fundraising, investors
Founder, CEO, and Chairman
Bespoke Biotherapeutics
Advises on: Product development, commercialization, regenerative medicine, oncology, hematology, organ transplantation, cardiovascular therapeutics
Partner
11.2 Capital
Advises on: Customer discovery, GTM strategy, recruiting, funding
Managing Partner
Circularis Partners/Self
Advises on: Past roles, company formation, early stage execution
CFO
Imago Biosciences
Advises on: Company concept, vision
Partner
Quarles & Brady LLP
Advises on: Early-stage startup legal issues, pitch decks, business strategy, fundraising, customer negotiations
General Partner
Qral Ventures
Advises on: Pitches, commercialization strategy, networking, leadership, entrepreneurship
Clinical Professor & Director, Center for Leadership
Northwestern University
Advises on: Leading others, building teams, problem solving
Professor of Entrepreneurship, Venture Capital and Practice
Northwestern University
Advises on: Corporate, technology, venture capital, transactional matters
CEO
NuMat Technologies
Advises on: Early-stage commercialization
CEO
Minicorn
Advises on: Mentoring multiple Techstars programs across the country
General Counsel
BYJ Law
Advises on: Requirements, scalability, business solutions
Vice President
OMX Ventures
Advises on: Commercialization path, company building, pitches
Senior Associate
Solasta Ventures
Advises on: Brainstorming, storytelling, early-stage projects
VP, Legal
Levo Therapeutics
Advises on: General corporate landscape, funding
Founder
Travertine Labs
Advises on: Strategy, general management, team dynamics/culture, highly technical R&D
Principal
Osage University Partners
Advises on: Pitch deck feedback, fundraising strategy, therapeutics industry landscape
Founder and Managing Director
SPRIG Equity
Advises on: Market fit analysis, clinical trial and regulatory guidance, commercialization, reimbursement, board dynamics/governance, general management
Principal, Co-Founder
Ontogen Medtech
Advises on: Mechanical hardware design and simulation
President
Parmelee Consulting
Advises on: Resubmission strategies, team building, navigating the SBIR/STTR program
CEO, CSO and Co-Founder
Singleton Bio
Advises on: Developing therapeutics at early-stage companies, helping teams refine novel ideas and build strong companies
Partner
Extera Partners
Advises on: Strategic global partnerships, technological innovations
Associate Director of Outreach
Deerfield Management
Advises on: Therapeutic hypothesis rationale, asset positioning, funding
Medical Director of Dermatology - Medical Affairs
AbbVie
Advises on: Drug development, label negotiations, global product launch
Principal
Osage University Partners
Advises on: Startup formation strategy, product ideation, fundraising
Founder, Strategic Advisor and Executive Coach
Aspire To Grow Consulting
Advises on: Navigating clinical trials, networking, vendor solutions
Principal
KdT Ventures
Advises on: Pitch preparation, company strategy, industry landscape, fundraising
Ben Andrew brings more than 25 years of experience analyzing medical technology companies as a sell-side analyst, combined with his work as a strategist driving product and business model innovation at Intuitive Surgical, the leading robotic surgery company. Throughout his career, he has focused on identifying and developing transformational innovations rather than incremental "me-too" products. He is passionate about helping early-stage companies find the most direct path to meaningful patient impact.
Kairos Ventures invests in great ideas and teams emanating from the top universities of the world in the physical sciences, life sciences, and high-tech arenas. My team and I are responsible for sourcing opportunities, conducting diligence, and making investment recommendations. Over the last few years, we have identified and conducted diligence for hundreds of opportunities, sourced from thousands of pitches received. I can help you with structuring and refining your pitch, developing your business plan, and systematically evaluate and prioritize strategic alternatives.
I'm a Kellogg adjunct Faculty member and business owner with a background in medical device positioning and commercialization. I have 25 years of experience in healthcare and have provided strategic marketing insight for a variety of medical technology companies ( medical device, diagnostic, wearables and health IT)ranging from venture-backed start-ups to Fortune 500 companies. I work closely with clients on the entire spectrum of marketing needs: from early- stage market development strategies to downstream launch execution and commercialization efforts.
Founding Scientist, EVP Drug Discovery & Early Development
Flare Therapeutics
Trained as a chemist, I am broadly experienced in contemporary drug discovery and early development from the perspective of both large pharma and biotech. I have served on biotech boards of directors, both public and private and have consulted for companies, venture firms, not-for-profits and academic institutions. I have a broad therapeutic focus, with primary interests in oncology and neuroscience. I can help provide general feedback on science, broad aspects of company formation and the translation of scientific concepts into clinically relevant small molecule therapeutic agents.
Associate Director, Alliances and Program Management
Caliber at Scripps Research
I am a scientist responsible for overseeing a portfolio of preclinical programs (small molecule, biologics, CAR-T) and establishment and management of partnerships with biotech and pharmaceutical companies. In my previous role, I led efforts focused on mechanistic characterization of drug candidates across different therapeutic areas (oncology, immunology, neuroscience). My scientific background is in synthetic chemistry and chemical biology. I can help you identify opportunities for therapeutic discovery, build therapeutic program packages and development plans, and understand the industry landscape.
I am a physical-organic chemist with expertise in colloid science, interfacial engineering, and complex aqueous formulations across water treatment, semiconductor, and medical device industries. I have 25 years of diversified industrial R&D experience with emphasis on translating technical innovation to new products that can be scaled and meet customer requirements. I can help identify critical path milestones, common failure modes, and facilitate acquisition of top talent for growing start-ups.
I am an investor, engineer, product manager, and entrepreneur who has managed investments in 80+ early stage startups including 3 IPOs and several exits of $500M, $300M, and more. My work focuses on identifying, conducting diligence, investing, and mentoring founders of startups who are solving problems with large human impact and upside for financial return. I can help you to evaluate an opportunity, launch your startup, and navigate operations, funding, governance, and strategy.
I previously worked for 10 years at SpaceX in the Avionics department. The majority of my time was spent on technical program management on the Avionics architecture of the Falcon launch vehicle and integrated opto-mechanical design for an in-space laser communication device. My specific areas of focus was system design, as well as the hardware development for the interfaces between electrical, mechanical, and environmental requirements. Since leaving SpaceX, I have worked at a Seed-stage venture capital firm focusing in the sustainability space. I can help you with expediting hardware product development cycles, and preparing pitch and fundraising materials prior to meeting with investors.
I am the Founder, CEO, and Chairman of Bespoke Biotherapeutics, developing genome-engineered B-cell therapeutics for hemophilia A and HER2+ breast cancer, and co-founder of a stealth clinical-stage brain-regeneration company. I previously held executive roles at Radimmune, Medeor, Talon, where I led Marqibo® from IND to FDA accelerated approval and acquisition, and Nuvelo. Earlier, I served as Chief of Hematology and Coagulation Medicine at the Cleveland Clinic. A Northwestern HPME graduate, I trained at Barnes/Washington University and completed hematology/oncology fellowships and post-doctoral work at Tufts.
My greater than 15 years of private and public company C-suite product development and commercialization know-how spans cell therapies, radioimmunotherapies, protein therapeutics, aptamers, and nanoparticle-targeted small molecules in the regenerative medicine, oncology, hematology, organ transplantation and cardiovascular therapeutic spaces.
I'm an early stage deep tech VC and former engineer with expertise in AI/ML and data infrastructure, satellites and sensing, energy storage and generation, and quantum technologies. Over 8 years as a VC, I've helped early stage startups with customer discovery, GTM strategy, recruiting, and funding.
Geoffrey Duyk
Managing Partner
Circularis Partners/Self
I am a physician-scientist/entrepreneur/investor with 30+ yrs of experience in biotechnology including industrial applications of biotechnology. I have been successfully involved in early stage (company formation), venture stage and growth stage companies as a founder, operator, investor, and BOD member. I can advise mentees on any matter related to your various roles in the past, with an emphasis on company formation and early stage execution.
I am a former VC and now a serial biotech entrepreneur with a strong foundation in management, primarily operations and finances of early-stage startups. Currently, as the CFO of Imago Biosciences, I manage day-to-day operations, finance, legal, HR and marketing-related activities. I can work with you in taking your vision, technology or science from a concept to a company.
I am an attorney at Quarles and Brady in Chicago and I lead our startups practice nationwide. I represent around 75 or so startups across the country and have had four of my own startups (including one active early-stage startup). I am very familiar with all kinds of early-stage startup legal issues ranging from equity documentation, trademarks and patent matters, fundraising (including SAFEs and convertible notes), labor and employment issues, and stock option plans. I'm also happy to review pitch decks and to provide general business strategy for fundraising rounds and negotiations with potential customers.
Dimitra Georganopoulou
General Partner
Qral Ventures
I am a chemist by training and have experience as a biotech professional with deep knowledge of personalized medicine projects, therapeutics, medical devices, diagnostics, and Health IT. In my various roles, I have mentored and guided innovators solving health and medical challenges and have led due diligence teams for various investment firms. I can help you with providing feedback on pitches, provide commercialization strategy pathways, offering perspectives from tech transfer and the venture world, and can help connect you with networking for your career, leadership or entrepreneurship in general.
Clinical Professor & Director, Center for Leadership
Northwestern University
I work globally with boards of directors and in the c-suite on the challenges that affect leaders in these roles. I can best help you with the intangible aspects of leading others, building teams, and structuring conversations to solve hard problems - the ones that usually keep people up at night.
Professor of Entrepreneurship, Venture Capital and Practice
Northwestern University
I am a corporate attorney with 25+ years of practicing transactional law in the fields of venture capital and early stage financing, entrepreneurship, and contracts. Currently, I spend most of my time teaching classes around entrepreneurship at Northwestern Pritzker School of Law, including venture capital, advanced contracts, and the entrepreneurship law clinic. I can help advise entrepreneurs and start-up businesses on corporate, technology, venture capital and other transactional matters.
I am an entrepreneur with a JD/MBA and an undergraduate degree in engineering from Northwestern. I am a co-founder of NuMat Technologies, an advanced materials company focused on nanoporous materials for separation, purification and encapsulation applications in the semiconductor, industrial defense and life science sectors. I have built this Northwestern company from ground zero and have now raised multiple rounds of capital from strategic and institutional investors. I'm most interested in helping faculty co-founders think through how best to commercialize their inventions at the earliest stages.
I am an author and entrepreneur. While at Northwestern, I started Design for America, a national network of student-led design studios. I co-founded SwipeSense, a healthcare technology platform to eliminate medical errors in US hospitals and raised $24M to implement it in over 100 hospitals and health systems. SwipeSense was ultimately acquired by SC Johnson. Most recently, I co-authored "Exit Right: How to Sell Your Startup, Maximize your Return, & Build your Legacy" with Mark Achler. I care deeply about education and mentor multiple Techstars programs across the country.
Re-imagining legal strategy: VC-backed companies need to have legal, regulatory, compliance, privacy expertise appropriate for the size and stage of the organization. I'm a senior legal executive with experience as General Counsel and Chief Compliance and Privacy Officer of several venture-backed and emerging/high growth companies, including a public biotech company. I can help you determine what is required, what is scalable, and create solutions that will move the business forward.
I am a molecular biologist with an extensive background in biotech venture investing and company creation. Since moving from the bench to the board room, I have focused on commercializing early-stage technology and serving on several boards. I can help you understand the commercialization path, provide feedback on company building and help prepare company pitches.
I'm currently a biotech investor based in Boston, and am a scientist (molecular biologist) by training. Our investments are mainly focused on early stage (private) therapeutics/drug dev ventures, and we are therapeutic area-, modality-, and stage-agnostic. I can help you by sharing what I've learned being on the investor side of the table in an informal and transparent way. I also enjoy brainstorming how to tell your story and determining next steps for early stage projects. I'm looking forward to building relationships where we all learn from each other.
I am a corporate attorney with experience helping life science companies scale. I can help new executives understand the general corporate landscape and prepare to meet with counsel as you grow toward funding.
I'm a Silicon Valley AI founder turned independent consultant, startup mentor, and Northwestern faculty member. I returned to Chicago after almost a decade in the Valley as founding CEO and later Chief Science Officer of Citrine Informatics, which has grown into a leading provider of enterprise AI for the materials industry.
Drawing on both my experience and educational background (PhD/MBA), I bring both technical and business lenses to mentorship. I specialize in working with technical founders and deeptech ventures on strategy, general management, and team dynamics/culture. I also enjoy helping teams align highly technical R&D with business objectives.
I am a neuroscientist by training with an extensive background in helping academic founders navigate the commercialization of their research and in working with biopharma companies across growth stages, project types and therapeutic areas. At OUP, I am currently a Principal, leading investments in therapeutics. I can help you with pitch deck feedback, fundraising strategy and understanding the industry landscape for therapeutics opportunities.
I'm an investor with corporate/strategic and private investment experience, a business operator with large and small companies, and an adjunct professor in the area of medical products commercialization and financing. I have invested in and worked with fifteen companies to date that have been acquired or gone public. My areas of expertise include product market fit analysis, clinical trial and regulatory guidance, commercialization, reimbursement, board dynamics/governance and general management.
I am an engineer with over 12 years experience in new product development, filling medtech R&D roles across both startups and large companies leading several products from concept to launch, spanning Class I, II and III. My main core competency is in front-end innovation, design, strategy, and development of medical technology solutions. My technical expertise is within the realm of mechanical hardware design and simulation, spanning topics including complex electromechanical system design, injection molded plastics, nitinol, LSR silicone, MEMS, intravascular cardiac devices and catheters.
I am a consultant specializing in non-dilutive federal grant programs to support the development of innovative technology (SBIR/STTR), specifically within National Institutes of Health (NIH) and National Science Foundation (NSF). I provide support on strategy development, team building and project design (approach), as well as providing full support during the application process through submission, preparation for award and post-award management of SBIR/STTR grants. I can answer strategy related questions about participating in the program, approach, resubmission strategies (for unfunded proposals), team building and other aspects of navigating the SBIR/STTR program within NIH and NSF.
Yan Poon is biochemist-trained biotech entrepreneur with experience developing therapeutics at early-stage companies from discovery through Phase 2 clinical development. Yan has also worked on investment diligence at a top-tier venture capital firm, focusing primarily on therapeutics. With experience spanning both company building and venture evaluation, Yan helps teams refine novel ideas, build strong companies, and develop the data packages that investors want to see.
I am a strategic marketeer with over 25 years of experience in upstream strategic marketing leadership positions with global healthcare companies, managing innovative medical device and healthcare IT products from concept to global commercialization. Diverse markets, multiple modalities, diagnostics, monitoring, AI-based expert systems, and image-guided therapy. Currently working with potentially game changing young innovative companies in the development of early strategic partnerships with global market leaders. I am interested to support innovative teams at all stages in their effort to translate technological innovations into winning products.
I am a molecular and cell biologist by training with experience working on drug discovery projects in the rare disease and cancer spaces. My current work focuses on translating academic research into fully integrated drug discovery programs. I can help think through rationale behind therapeutic hypothesis, how position an asset in the landscape of current clinical strategies, estimate patient population, and how to fund a novel therapeutic idea.
I am a Physician executive with extensive experience in healthcare, clinical trials, and biotech, with a focus on psychiatry, neurology, immunology, and dermatology. Over the years, I've supported drug development, FDA label negotiations and led the launch of multiple global products and strategies across a number of organizations, honing my ability to navigate complex challenges and drive impactful outcomes.
Our fund invests in university spinouts across the broad range of physical sciences, software, and life sciences. I focus on the tech side of the house and can help with startup formation strategy, product ideation, and fundraising.
I have 30+ years in the Biopharma space and have been involved in a range of critical R & D areas, including IND planning, protocol development, operational planning, team development and comprehensive risk identification and mitigation planning, with a particular focus on optimizing vendor selection, managing Key Opinion Leaders (KOLs), and ensuring regulatory compliance. I can help you navigate the complexities of clinical trials through all phases of development to NDA approval, overcoming clinical trial operational challenges and leveraging industry networks while focusing on fit for purpose vendor solutions.
MD by training with a background in translational oncology and neuroscience research. Currently, I am seed-stage biotech investor with significant experience growing platform therapeutics companies. I can help you with pitch preparation, assess your company strategy, understanding the industry landscape, and preparing for a fundraise.